Australia as Your Competitive Advantage
Australia offers a rare combination of financial incentive, regulatory alignment, and clinical efficiency that few manufacturing geographies can match. BioCina is built to convert each of those advantages into tangible program outcomes.
Reduce Your Program Cost
Australia's R&D Tax Incentive returns up to 43.5% of eligible R&D expenditure as a refundable cash offset for qualifying companies, including pre-revenue entities.
BioCina provides the technical documentation required to support R&D Tax claims and works with a network of specialist advisors who can assess your eligibility, structure your engagement, and help you capture the full value of the incentive from day one.
Explore Your Eligibility
Get to Clinic Faster
Australia's CTN pathway allows eligible early-phase trials to begin without a full IND equivalent, with trial initiation often possible within 6 to 8 weeks of submission. GMP material released at BioCina moves directly into clinic, and CTN data is fully accepted by the FDA and EMA for later submissions.
Source: Australian Clinical Trial Handbook, TGA, updated October 2024
The Australian Advantage
Global Gateway
Strategic bridge between Asia- Pacific and Western markets for global program scalability.
Stable and Secure
Western democracy with political stability, robust IP protection, and trusted legal frameworks.
Globally Aligned
TGA GMP standards harmonised with FDA and EMA through PIC/S mutual recognition.
Connected Clinical Network
Fast-growing ecosystem of hospitals, CROs, and trial sites enabling rapid Phase I entry.
Thriving Life Sciences Ecosystem
Technically deep talent trained to TGA and FDA standard GMP environments from the outset.
BioCina in Australia
Our facilities hold active approvals from the world's most demanding regulatory authorities, with 50 years of manufacturing heritage and a supply reach spanning 140+ countries.
US FDA inspected and approved
EU GMP certified, EU Annex 1 aligned
TGA licensed for clinical and commercial manufacture
Health Canada recognised
ANVISA approved
0+
Approved products manufactured
0+
Countries supplied globally
0+
Years of continuous GMP manufacturing heritage
Ready to Move Forward?
Partner with BioCina and put Australia's advantages to work for your program.